Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav

Safety and Efficacy of Switching to the Travoprost/Timolol Maleate Fixed Combination (DUOTRAV®) From Prior Mono or Two-Drug Therapy in Germany

The purpose of this study is to assess the safety and efficacy of transitioning uncontrolled glaucoma patients to DuoTrav from other mono or adjunctive therapies.

Inclusion Criteria:

• Adults with primary open-angle glaucoma, ocular hypertension or pigment dispersion glaucoma.
• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Age related.
• Other protocol-defined exclusion criteria may apply.